China Resources Double Crane / Long Chain Fat Emulsion (C8-24)) was approved for production
Time of Update: 2021-03-11
was developed by the German company Belang and approved for listing in Europe in 1990 under the name "Lipofundina MCT/LCT", which was licensed for import and marketed in China in 2001 and has been listed and sold in dozens of countries around the world, including China, Europe, Russia, Saudi Arabia and Indonesia.
On October 3, 16 new confirmed cases were imported from abroad
Time of Update: 2020-12-05
October 3, 0-24 hours, 31 provinces (autonomous regions, municipalities directly under the Central Government) and Xinjiang Production and Construction Corps reported 16 new confirmed cases, all of w
Studying the ArfGAP-Dependent Conformational Changes in SNAREs
Time of Update: 2020-11-26
Vesicle SNAREs (v-SNAREs) are included with high fidelity into each transport vesicle generated in the cell.
The mechanism of high fidelity inclusion of SNAREs into transport vesicles is very difficult to study in vivo.
Dr. Zhang Lianshan of Hengrui Pharmaceuticals on "The Pain points and hopes of Chinese Pharmaceutical Innovation
Time of Update: 2020-08-20
In the end , Professor Xue Yu thanked Dr. Zhang Lianshan for his sharing and analysis, thanked Hengrui Pharmaceuticals for making good explorations in the field of research and development of innovative drugs, and hoped that more local enterprises could move towards the path of innovation and promote the development of national health and medicine.
Taiwan's new drugs will be on the market in the mainland as soon as the end of the year
Time of Update: 2014-04-10
Xu Mingneng, vice president of the Ministry of health and welfare, said that at present, one new drug in Taiwan has completed three phases of clinical trials and entered the stage of final inspection,